⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Securities Fraud Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Levi & Korsinsky Reminds Investors of September 14, 2026
accessnewswire.com
REGN
Regeneron Pharmaceuticals, Inc. (REGN) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before September 14, 2026 Lead Plaintiff Deadline
prnewswire.com
REGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
accessnewswire.com
EYPT
REGN
REGN LAWSUIT ALERT: Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. Investors - Lead Plaintiff Deadline September 14, 2026
accessnewswire.com
REGN
REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Pomerantz LLP Issues Important Reminder to Investors in Regeneron Pharmaceuticals, Inc. of Class Action Filing – REGN
accessnewswire.com
REGN
Specialty Pharmaceuticals Market (2026-2031) - Rising Prevalence of Chronic and Rare Diseases Drives Growth
globenewswire.com
ABBV
AMGN
AZN
BIIB
BMRA
BMY
JNJ
MRK
NVS
PFE
REGN
SNY
TEVA
VRTX
Regeneron Pharmaceuticals, Inc. (REGN) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 14, 2026 Deadline
accessnewswire.com
REGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
prnewswire.com
EYPT
REGN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
prnewswire.com
REGN